OpenEvidence Expands in Florida After $250 Million Raise Lifts Valuation to $12 Billion
Updated
Updated · NBC Boston · May 12
OpenEvidence Expands in Florida After $250 Million Raise Lifts Valuation to $12 Billion
1 articles · Updated · NBC Boston · May 12
$250 million in fresh funding is fueling OpenEvidence’s Florida expansion, extending the AI diagnostic-support company’s move from Cambridge to South Florida.
The company said backing from a national medical society is helping that push, adding institutional support to a platform often described as “ChatGPT for doctors.”
Founded in 2022, OpenEvidence operates a medical search engine that draws on peer-reviewed literature rather than the broader internet to help doctors with diagnoses.
Its latest round—the biggest by a South Florida startup in the first quarter of 2026—helped lift OpenEvidence’s valuation to $12 billion, with total funding nearing $700 million from investors including Google Ventures, Sequoia Capital and Nvidia.
OpenEvidence's free tool is used by most US doctors. What is the hidden cost?
Can an AI valued at $12 billion overcome the biases baked into its own medical data?
As AI diagnoses surge, who is liable when the technology inevitably makes a mistake?
OpenEvidence Secures $250M Series D at $12B Valuation: The AI Powerhouse Transforming Medical Search
Overview
In January 2026, OpenEvidence secured a landmark $250 million Series D funding round, which doubled its valuation to $12 billion and made it the most valuable healthcare AI company globally. This funding round, the largest for a South Florida startup that quarter, attracted top investors like Thrive Capital, DST Global, Google Ventures, Sequoia Capital, and Nvidia, reflecting strong confidence in OpenEvidence’s innovative approach. The company’s specialized AI-powered medical search engine helps clinicians quickly find and synthesize critical information from peer-reviewed journals and clinical guidelines, driving its rapid growth and market leadership.